Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1979 Apr;32(4):368–372. doi: 10.1136/jcp.32.4.368

An immunohistochemical study of the significance of HCG secretion by large bowel adenocarcinomata.

C H Buckley, H Fox
PMCID: PMC1145674  PMID: 447871

Abstract

A series of five benign and 60 malignant colonorectal neoplasms has been examined immunohistochemically for the presence of HCG. This hormone was not demonstrated in any of the benign tumours but was present in 43% of the malignant neoplasms. The incidence of HCG secretion was unrelated to the sex of the patient but tended to be decreased in patients of advanced age. The HCG-containing tumours, which were predominantly from the left side of the large intestine, had all penetrated the full thickness of the bowel wall while a significant proportion of those tumours lacking HCG were still confined to the bowel wall. Despite the greater degree of local aggressiveness shown by the HCG-secreting tumours there was no correlation between HCG production and the presence of local metastases but, as the presence of HCG is associated with local invasion, it is suggested that preoperative immunohistochemical studies of HCG in biopsies of large bowel neoplasms may be of value in the planning of surgical procedures.

Full text

PDF
368

Images in this article

370Figure
on p.370

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braunstein G. D., Vaitukaitis J. L., Carbone P. P., Ross G. T. Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med. 1973 Jan;78(1):39–45. doi: 10.7326/0003-4819-78-1-39. [DOI] [PubMed] [Google Scholar]
  2. Contractor S. F., Davies H. Effect of human chorionic somatomammotrophin and human chorionic gonadotrophin on phytohaemagglutinin-induced lymphocyte transformation. Nat New Biol. 1973 Jun 27;243(130):284–286. doi: 10.1038/newbio243284a0. [DOI] [PubMed] [Google Scholar]
  3. Fabris N., Piantanelli L., Muzzioli M. Differential effect of pregnancy or gestagens on humoral and cell-mediated immunity. Clin Exp Immunol. 1977 May;28(2):306–314. [PMC free article] [PubMed] [Google Scholar]
  4. Gailani S., Chu T. M., Nussbaum A., Ostrander M., Christoff N. Human chorionic gonadotrophins (hCG) in non-trophoblastic neoplasms. Assessment of abnormalities of hCG and CEA in bronchogenic and digestive neoplasms. Cancer. 1976 Oct;38(4):1684–1686. doi: 10.1002/1097-0142(197610)38:4<1684::aid-cncr2820380440>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  5. Goldenberg D. M., Pant K. D., Dahlman H. L. Antigens associated with normal and malignant gastrointestinal tissues. Cancer Res. 1976 Sep;36(9 Pt 2):3455–3463. [PubMed] [Google Scholar]
  6. Graham R. C., Jr, Karnovsky M. J. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem. 1966 Apr;14(4):291–302. doi: 10.1177/14.4.291. [DOI] [PubMed] [Google Scholar]
  7. Horne C. H., Reid I. N., Milne G. D. Prognostic significance of inappropriate production of pregnancy proteins by breast cancers. Lancet. 1976 Aug 7;2(7980):279–282. doi: 10.1016/s0140-6736(76)90731-5. [DOI] [PubMed] [Google Scholar]
  8. Kahn C. R., Rosen S. W., Weintraub B. D., Fajans S. S., Gorden P. Ectopic production of chorionic gonadotropin and its subunits by islet-cell tumors. A specific marker for malignancy. N Engl J Med. 1977 Sep 15;297(11):565–569. doi: 10.1056/NEJM197709152971101. [DOI] [PubMed] [Google Scholar]
  9. McManus L. M., Naughton M. A., Martinez-Hernandez A. Human chorionic gonadotropin in human neoplastic cells. Cancer Res. 1976 Sep;36(9 Pt 2):3476–3481. [PubMed] [Google Scholar]
  10. Placental proteins and their subunits as tumor markers. Ann Intern Med. 1975 Jan;82(1):71–83. doi: 10.7326/0003-4819-82-1-71. [DOI] [PubMed] [Google Scholar]
  11. REGAN J. F., CREMIN J. H. Chorionepithelioma of the stomach. Am J Surg. 1960 Aug;100:224–233. doi: 10.1016/0002-9610(60)90295-6. [DOI] [PubMed] [Google Scholar]
  12. Rosen S. W., Becker C. E., Schlaff S., Easton J., Gluck M. C. Ectopic gonadotropin production before clinical recognition of bronchogenic carcinoma. N Engl J Med. 1968 Sep 19;279(12):640–641. doi: 10.1056/NEJM196809192791205. [DOI] [PubMed] [Google Scholar]
  13. Sternberger L. A., Hardy P. H., Jr, Cuculis J. J., Meyer H. G. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970 May;18(5):315–333. doi: 10.1177/18.5.315. [DOI] [PubMed] [Google Scholar]
  14. Tormey D. C., Waalkes T. P., Simon R. M. Biological markers in breast carcinoma. II. Clinical correlations with human chorionic gonadotrophin. Cancer. 1977 Jun;39(6):2391–2396. doi: 10.1002/1097-0142(197706)39:6<2391::aid-cncr2820390613>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  15. Walker R. A. Significance of alpha-subunit HCG demonstrated in breast carcinomas by the immunoperoxidase technique. J Clin Pathol. 1978 Mar;31(3):245–249. doi: 10.1136/jcp.31.3.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Weintraub B. D., Rosen S. W. Ectopic production of human chorionic somatomammotropin by nontrophoblastic cancers. J Clin Endocrinol Metab. 1971 Jan;32(1):94–101. doi: 10.1210/jcem-32-1-94. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES